X4P-001
X4P-001-RCCA
Phase 2 small_molecule completed
Quick answer
X4P-001 for Clear Cell Renal Cell Carcinoma is a Phase 2 program (small_molecule) at X4 Pharmaceuticals, Inc with 2 ClinicalTrials.gov record(s).
Program details
- Company
- X4 Pharmaceuticals, Inc
- Indication
- Clear Cell Renal Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed